|Appears in Collections:||Faculty of Health Sciences and Sport Journal Articles|
|Peer Review Status:||Refereed|
|Title:||Colorectal complications of end-stage renal failure and renal transplantation: a review|
|Author(s):||Parnaby, Craig N|
Barrow, Elizabeth J
Edirimanne, Senarath B
Parrott, Neil R
Frizelle, Frank A
|Keywords:||End-stage renal failure|
|Citation:||Parnaby CN, Barrow EJ, Edirimanne SB, Parrott NR, Frizelle FA & Watson A (2012) Colorectal complications of end-stage renal failure and renal transplantation: a review. Colorectal Disease, 14 (4), pp. 403-415. https://doi.org/10.1111/j.1463-1318.2010.02491.x|
|Abstract:||Aim: End-stage renal failure (ESRF) and renal transplant recipients are thought to be associated with an increased risk of colorectal complications. Method: A review of the literature was performed to assess the prevalence and outcome in both benign and malignant colorectal disease. Results: No prospective randomized studies assessing colorectal complications in ESRF or renal transplant were identified. Case series and case reports have described the incidence and management of benign colorectal complications. Complications included diverticulitis, infective colitis, colonic bleeding and colonic perforation. There was insufficient evidence to associate diverticular disease with adult polycystic kidney disease. Three population-based studies have shown up to a twofold increased incidence of colonic cancer but not rectal cancer for renal transplant recipients. Bowel cancer screening (as per the general population) by faecal occult blood testing appears justified for renal transplant patients; however, evidence suggests that consideration of starting screening at a younger age may be worthwhile because of an increased risk of developing colonic cancer. Two population-based studies have shown a threefold and 10-fold increased incidence of anal cancer for renal transplant recipients. A single case-control study demonstrated significant increased prevalence of anal human papillomavirus (HPV) and intraepithelial neoplasia (AIN) in patients with established renal transplants. Conclusions: Despite the lack of high-level evidence, ESRF and renal transplantation were associated with colorectal complications that could result in major morbidity and mortality. Bowel cancer screening in this patient group appears justified. The effectiveness of screening for HPV, AIN and anal cancer in renal transplant recipients remains unclear.|
|Rights:||The publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study.|
|Watson_Colorectal Disease_2012.pdf||Fulltext - Published Version||103.64 kB||Adobe PDF||Under Permanent Embargo Request a copy|
Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependent on the depositor still being contactable at their original email address.
This item is protected by original copyright
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/
If you believe that any material held in STORRE infringes copyright, please contact firstname.lastname@example.org providing details and we will remove the Work from public display in STORRE and investigate your claim.